Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1b Trial of CMV-MVA Triplex Vaccine in Haploidentical Stem Cell Donors and Recipients to Enhance CMV-Specific Immunity and Prevent CMV Viremia in Recipients of Hematopoietic Stem Cell Transplant

NCT07020533 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT07020533
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07020533 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1b Trial of CMV-MVA Triplex Vaccine in Haploidentical Stem Cell Donors and Recipients to Enhance CMV-Specific Immunity and Prevent CMV Viremia in Recipients of Hematopoietic Stem Cell Transplant
Lead sponsor
City of Hope Medical Center
Phase
Phase 1
Overall status
Recruiting
Start date
May 8, 2026
Completion date
May 30, 2029
Enrollment
46 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

accelerated phase chronic myeloid leukemia, bcr-abl1 positive, acute lymphoblastic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia, chronic phase chronic myeloid leukemia, bcr-abl1 positive, hematopoietic and lymphatic system neoplasm, hodgkin lymphoma, lymphoblastic lymphoma, myelodysplastic syndrome, myelofibrosis, myeloproliferative neoplasm, non-hodgkin lymphoma